10-Q: Gyrodyne LLC Reports Increased Net Assets in Liquidation Following Rights Offering

Gyrodyne LLC's net assets in liquidation increased to $35.39 million as of March 31, 2024, primarily due to a successful rights offering.

Summary

• Gyrodyne LLC reported net assets in liquidation of $35.39 million as of March 31, 2024, up from $30.72 million at the end of 2023.
• The increase is primarily attributed to a rights offering that generated approximately $4.4 million in net proceeds.
• The company is in the process of liquidating its assets, primarily real estate holdings in New York, and anticipates completing this process by the end of 2025.
• Gyrodyne is pursuing entitlements on its properties to increase their value before sale.
• The company is facing an Article 78 Proceeding related to a subdivision application for its Flowerfield property, which could delay the sale of the property.
• Estimated distributions to shareholders are approximately $16.09 per share, based on 2,199,308 shares outstanding, but this is subject to change based on the final sale prices of assets and liquidation costs.
• The company's strategy is to maximize the value of its properties through entitlements and strategic sales, with the goal of distributing proceeds to shareholders after settling debts and claims.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company has increased its net assets through a rights offering, it faces significant challenges, including legal proceedings and potential delays in its liquidation timeline. The decrease in estimated distribution per share is also a negative factor.

Positives

• The rights offering significantly increased the company's cash position, providing resources for entitlement efforts and legal proceedings.
• The company is actively pursuing entitlements to increase the value of its properties.
• Gyrodyne has retained JLL Capital Markets to market its properties, which could lead to a faster sale process.
• The company has a clear plan for liquidation and distribution of assets to shareholders.
• The company is actively managing its leases to improve operating cash flow.

Negatives

• The Article 78 Proceeding could delay the sale of the Flowerfield property and impact the overall liquidation timeline.
• The estimated distributions per share decreased from $19.51 to $16.09 due to the issuance of new shares at a discount.
• The company's liquidation timeline is subject to factors outside of its control, including regulatory approvals and legal proceedings.
• The company is incurring significant costs related to land entitlements and legal fees.
• The company's assumptions and estimates are based on completing the liquidation by December 31, 2025, and any changes to this timeline could impact the reported net assets.

Risks

• The Article 78 Proceeding could result in delays and additional costs.
• The company's ability to obtain required permits and authorizations is subject to factors beyond its control, including environmental concerns.
• The real estate market conditions could impact the sale prices of the properties.
• The company's estimates of liquidation costs and timelines could be inaccurate, affecting the final distributions to shareholders.
• The company is exposed to credit risk from its tenants, particularly those in the healthcare industry.
• The company's assumptions and estimates are based on completing the liquidation by December 31, 2025, and any changes to this timeline could impact the reported net assets.

Future Outlook

Gyrodyne anticipates completing the liquidation of its assets by the end of 2025, with the goal of maximizing value and distributions to shareholders. The company will continue to pursue entitlements on its properties and market them for sale. The timeline is subject to factors outside of the company's control, including the Article 78 Proceeding and regulatory approvals.

Management Comments

• Gyrodyne's corporate strategy is to pursue entitlements on our two remaining properties, so that they can be sold to one or more developers with increased development flexibility at higher prices, thereby maximizing value and distributions.
• Gyrodyne intends to dissolve after we complete the disposition of our assets, apply the proceeds to settle debts and claims, and then pay liquidating distributions to our shareholders.
• The Company believes the process of negotiating purchase agreements, securing final approvals and consummating the sale of our properties will culminate by year-end 2025.
• The Company intends to aggressively market its properties and negotiate contracts in an effort to complete the process as soon as practicable with the ultimate timeline being largely dependent on factors outside the Company's control.

Industry Context

The company's focus on medical office and industrial properties aligns with the demand for these types of real estate assets. The pursuit of entitlements to increase development flexibility is a common strategy in the real estate industry to maximize property values. The impact of the COVID-19 pandemic on commercial real estate, particularly office space, is a relevant factor affecting the company's operations and marketability of its properties.

Comparison to Industry Standards

• Gyrodyne's strategy of pursuing entitlements to increase property value is a common practice among real estate developers and investors.
• The company's liquidation approach is similar to other companies winding down operations, focusing on asset sales and debt settlement.
• The timeline for liquidation, estimated to be completed by the end of 2025, is within the typical range for complex real estate liquidations, but is subject to delays.
• The company's reliance on third-party appraisals and market data for asset valuation is consistent with industry standards.
• The company's use of discounted cash flow models to estimate net realizable value is a standard practice in real estate valuation.
• The company's focus on maximizing value through entitlements is similar to strategies employed by companies like Howard Hughes Corporation, which focuses on master-planned communities, and Brookfield Properties, which develops large-scale commercial real estate projects.

Legal Proceedings

• The company is defending against an Article 78 Proceeding related to the Flowerfield subdivision application.
• The company is subject to a Stipulation of Settlement from a previous class action lawsuit, which requires sales of properties to be at or above their 2014 appraised values.

Related Party Transactions

• The company has leasing arrangements with a not-for-profit organization where the company's Chairman serves as Chairman and a director, but receives no compensation or financial benefit.

Stakeholder Impact

• Shareholders will receive liquidating distributions after the sale of assets and settlement of debts and claims.
• Employees may receive retention bonuses upon the sale of properties.
• Tenants may be impacted by the sale of the properties and any changes in ownership or management.
• Creditors will be paid from the proceeds of asset sales.

Next Steps

• Continue to pursue entitlements for the Flowerfield and Cortlandt Manor properties.
• Defend against the Article 78 Proceeding.
• Market the properties for sale through JLL Capital Markets.
• Negotiate and execute purchase agreements for the properties.
• Complete the liquidation process by the end of 2025.

Key Dates

Keywords

liquidation, real estate, entitlements, rights offering, property sales, Article 78 Proceeding, Flowerfield, Cortlandt Manor, distributions, net assets